NCT02581059 - Efficacy of Ginseng for Patients on Regorafenib | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 22, 2018

Study Completion Date

June 22, 2018

Conditions

Colorectal CancerPalliative MedicineSupportive Care

Interventions

DRUG

Regorafenib

All subjects will receive regorafenib 160 mg orally once daily for the first 21 days of each 28-day cycle for 2 cycles.

DIETARY_SUPPLEMENT

Ginseng

Subjects randomized to ginseng will receive 1,000 mg orally twice every day of each 28-day cycle for 2 cycles.

Trial Locations (5)

Gettysburg Cancer Center, Gettysburg

Comprehensive Cancer Center at Wake Forest Baptist, Winston-Salem

Indiana Univeristy Melvin and Bren Simon Cancer Center, Indianapolis

IU Health Central Indiana Cancer Centers, Indianapolis

Altantic Health System, Morristown